A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Clinical trial NCT07465263 · RECRUITING
Trial details
- NCT number
- NCT07465263
- Sponsor
- CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2028-02-28
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.